Concerned about your investment in Neurotrope Inc.?
Are you concerned about your investment in Neurotrope Inc.? If so, the securities attorneys at The White Law Group may be able to help you by filing a FINRA Dispute Resolution claim against the brokerage firm that sold you the investment.
Neurotrope is a clinical-stage biotech company leveraging Bryostatin-1 and its analogues to discover and develop targeted therapeutics for neurodegenerative diseases and developmental disorders, according to its website.
The company filed a form D to raise capital from 136 investors in 2015, according to filings with the SEC. The total offering amount was purportedly $20,000,000. The sales commissions and fees paid were estimated at 10% of the offering amount.
Filing a Complaint against your Brokerage Firm
The White Law Group is investigating the liability that FINRA registered brokerage firms may have for improperly recommending high-risk investments to investors.
The problem with biotechnology investments such as Neurotrope Inc. is that they typically involve a high degree of risk. The research and development process for tech and pharma companies often involves costly and lengthy clinical testing trials that yield specific data. If the expected data or end points are not met, that could be bad news for investors.
Without a strong understanding of the company and its basic operations, investors may be looking at serious losses.
Broker dealers are required to perform adequate due diligence on any investment they recommend and to ensure that all recommendations are suitable for the investor. Firms that fail to do so, may be held responsible for any losses in a FINRA arbitration claim.
If you have concerns regarding investment losses in Neurotrope Inc. please call the securities attorneys at The White Law Group for a free consultation at 888-637-5510.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Franklin, Tennessee.
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visit https://www.whitesecuritieslaw.com.
Tags: Neurotrope Inc. class action, Neurotrope Inc. complaints, Neurotrope Inc. investigation, Neurotrope Inc. investment losses, Neurotrope Inc. lawsuit, Neurotrope Inc. update, Neurotrope Inc.news, Neurotrope Inc.shareholders Last modified: September 8, 2020